{
    "source_url": "https://clinicaltrials.gov",
    "register_url": "https://priyalifescience.com/clinical-trials-china",
    "fetched_at": "2026-09-20T17:51:48+00:00",
    "registry_total_matching_open_statuses": 19029,
    "count": 19029,
    "page": 1,
    "per": 25,
    "results": [
        {
            "nct_id": "NCT06974968",
            "title": "Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 2",
            "lead_sponsor": "XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.",
            "conditions": [
                "Spinal Cord Injury",
                "Safety",
                "Efficacy",
                "Clinical Trial"
            ],
            "sites": [
                "Guangzhou"
            ],
            "enrollment": 60,
            "start_date": "2028-05-25",
            "registry_url": "https://clinicaltrials.gov/study/NCT06974968"
        },
        {
            "nct_id": "NCT06990178",
            "title": "Adaptive Neoadjuvant Therapy for Esophageal Cancer",
            "status": "ENROLLING_BY_INVITATION",
            "phase": "Not applicable",
            "lead_sponsor": "Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center",
            "conditions": [
                "Esophageal Carcinoma",
                "Neoadjuvant Therapy"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 43,
            "start_date": "2028-03-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT06990178"
        },
        {
            "nct_id": "NCT07044700",
            "title": "Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction",
            "status": "NOT_YET_RECRUITING",
            "phase": "Observational",
            "lead_sponsor": "Boehringer Ingelheim",
            "conditions": [
                "Heart Failure of Reduced Ejection Fraction (HFrEF)"
            ],
            "sites": [
                "Beijing"
            ],
            "enrollment": 5000,
            "start_date": "2028-01-31",
            "registry_url": "https://clinicaltrials.gov/study/NCT07044700"
        },
        {
            "nct_id": "NCT07382375",
            "title": "AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection",
            "status": "NOT_YET_RECRUITING",
            "phase": "Not applicable",
            "lead_sponsor": "Nanjing Medical University",
            "conditions": [
                "Aortic Aneurysm and Dissection"
            ],
            "sites": [
                "Beijing",
                "Changzhou",
                "Chengdu",
                "Fuzhou",
                "Guangzhou",
                "Nanchang",
                "Nanjing",
                "Shanghai"
            ],
            "enrollment": 300,
            "start_date": "2027-12-31",
            "registry_url": "https://clinicaltrials.gov/study/NCT07382375"
        },
        {
            "nct_id": "NCT07318909",
            "title": "To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase EARLY_PHASE1",
            "lead_sponsor": "Gritgen Therapeutics Co., Ltd.",
            "conditions": [
                "Phenylketonuria (PKU)"
            ],
            "sites": [
                "Hefei"
            ],
            "enrollment": 9,
            "start_date": "2027-12-31",
            "registry_url": "https://clinicaltrials.gov/study/NCT07318909"
        },
        {
            "nct_id": "NCT07789483",
            "title": "An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 3",
            "lead_sponsor": "Alexion Pharmaceuticals, Inc.",
            "conditions": [
                "Transthyretin Amyloid Cardiomyopathy (ATTR-CM)"
            ],
            "sites": [
                "Beijing",
                "Chongqing",
                "Guangzhou",
                "Guiyang",
                "Harbin",
                "Wuhan",
                "Changsha",
                "Nanjing"
            ],
            "enrollment": 1180,
            "start_date": "2027-11-23",
            "registry_url": "https://clinicaltrials.gov/study/NCT07789483"
        },
        {
            "nct_id": "NCT07707882",
            "title": "Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 2",
            "lead_sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine",
            "conditions": [
                "Tenosynovial Giant Cell Tumor, Diffuse"
            ],
            "sites": [
                "Hangzhou"
            ],
            "enrollment": 84,
            "start_date": "2027-10-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT07707882"
        },
        {
            "nct_id": "NCT07691645",
            "title": "Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 2",
            "lead_sponsor": "Xiang-Qian",
            "conditions": [
                "HCC - Hepatocellular Carcinoma",
                "Chinese Herbal Medicine",
                "ICG (Indocyanine Green)",
                "Overall Survival (All-cause Mortality)"
            ],
            "sites": [
                "Hangzhou"
            ],
            "enrollment": 120,
            "start_date": "2027-09-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT07691645"
        },
        {
            "nct_id": "NCT07735143",
            "title": "iMORE+ Study: A Multi-Omics Cohort Study of Major Depressive Disorder",
            "status": "NOT_YET_RECRUITING",
            "phase": "Observational",
            "lead_sponsor": "Shanghai Mental Health Center",
            "conditions": [
                "Major Depressive Disorder (MDD)"
            ],
            "sites": [
                "Shanghai"
            ],
            "enrollment": 150,
            "start_date": "2027-09-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT07735143"
        },
        {
            "nct_id": "NCT07170293",
            "title": "Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors",
            "status": "RECRUITING",
            "phase": "Phase 2",
            "lead_sponsor": "Tianjin Medical University Second Hospital",
            "conditions": [
                "Solid Cancers"
            ],
            "sites": [
                "Tianjin"
            ],
            "enrollment": 15,
            "start_date": "2027-08-31",
            "registry_url": "https://clinicaltrials.gov/study/NCT07170293"
        },
        {
            "nct_id": "NCT07751003",
            "title": "Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support",
            "status": "NOT_YET_RECRUITING",
            "phase": "Not applicable",
            "lead_sponsor": "Sir Run Run Shaw Hospital",
            "conditions": [
                "COPD (Chronic Obstructive Pulmonary Disease)",
                "Acute Exacerbation of COPD",
                "Hypercapnia"
            ],
            "sites": [
                "Zhengzhou",
                "Changsha",
                "Hangzhou",
                "Wenling"
            ],
            "enrollment": 236,
            "start_date": "2027-08-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT07751003"
        },
        {
            "nct_id": "NCT07389499",
            "title": "A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase EARLY_PHASE1",
            "lead_sponsor": "Grit Biotechnology",
            "conditions": [
                "IgA Nephropathy (IgAN)",
                "Membranous Nephropathy",
                "ANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)",
                "Refractory Podocytopathy"
            ],
            "sites": [
                "Shanghai"
            ],
            "enrollment": 30,
            "start_date": "2027-08",
            "registry_url": "https://clinicaltrials.gov/study/NCT07389499"
        },
        {
            "nct_id": "NCT07781748",
            "title": "Improving Quality of Informal Care for People With Schizophrenia",
            "status": "NOT_YET_RECRUITING",
            "phase": "Not applicable",
            "lead_sponsor": "Chinese University of Hong Kong",
            "conditions": [
                "Schizophrenia"
            ],
            "sites": [
                "Chengdu"
            ],
            "enrollment": 228,
            "start_date": "2027-07-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT07781748"
        },
        {
            "nct_id": "NCT04433221",
            "title": "Combination Immunotherapy Targeting Sarcomas",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 1/2",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "Sarcoma",
                "Osteoid Sarcoma",
                "Ewing Sarcoma"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 20,
            "start_date": "2027-07-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT04433221"
        },
        {
            "nct_id": "NCT03645486",
            "title": "Lentiviral Gene Therapy for CGD",
            "status": "NOT_YET_RECRUITING",
            "phase": "Not applicable",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "Chronic Granulomatous Disease"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 10,
            "start_date": "2027-07-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT03645486"
        },
        {
            "nct_id": "NCT04980703",
            "title": "Grain Moxibustion Treatment on Insomnia: a Randomized Controlled Trial",
            "status": "NOT_YET_RECRUITING",
            "phase": "Not applicable",
            "lead_sponsor": "Shanghai Institute of Acupuncture, Moxibustion and Meridian",
            "conditions": [
                "Sleep Initiation and Maintenance Disorders"
            ],
            "sites": [
                "Shanghai"
            ],
            "enrollment": 102,
            "start_date": "2027-07-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT04980703"
        },
        {
            "nct_id": "NCT04016129",
            "title": "CAR-T Immunotherapy Targeting CD19- ALL",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 1/2",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "B-cell Leukemia"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 100,
            "start_date": "2027-07-01",
            "registry_url": "https://clinicaltrials.gov/study/NCT04016129"
        },
        {
            "nct_id": "NCT07477600",
            "title": "cfMSC Stem Cell Therapy Targeting COPD",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 1/2",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "Chronic Obstructive Pulmonary Disease (COPD)"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 30,
            "start_date": "2027-06-30",
            "registry_url": "https://clinicaltrials.gov/study/NCT07477600"
        },
        {
            "nct_id": "NCT06006741",
            "title": "Universal CAR-T Cells Targeting Multiple Myeloma",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 1",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "Multiple Myeloma in Remission"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 20,
            "start_date": "2027-06-30",
            "registry_url": "https://clinicaltrials.gov/study/NCT06006741"
        },
        {
            "nct_id": "NCT06739226",
            "title": "Combination Immunotherapy Targeting Melanoma",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 1/2",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "Melanoma"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 30,
            "start_date": "2027-06-30",
            "registry_url": "https://clinicaltrials.gov/study/NCT06739226"
        },
        {
            "nct_id": "NCT06435910",
            "title": "Engineered Dendritic Cell Vaccines for Multiple Myeloma",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 1",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "Multiple Myeloma or Plasmacytoma"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 10,
            "start_date": "2027-06-30",
            "registry_url": "https://clinicaltrials.gov/study/NCT06435910"
        },
        {
            "nct_id": "NCT05995041",
            "title": "Universal CAR-T Cells Targeting AML",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 1",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "Acute Myeloid Leukemia"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 30,
            "start_date": "2027-06-30",
            "registry_url": "https://clinicaltrials.gov/study/NCT05995041"
        },
        {
            "nct_id": "NCT03645460",
            "title": "Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)",
            "status": "NOT_YET_RECRUITING",
            "phase": "Not applicable",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 10,
            "start_date": "2027-06-30",
            "registry_url": "https://clinicaltrials.gov/study/NCT03645460"
        },
        {
            "nct_id": "NCT05995028",
            "title": "Universal 4SCAR7U Targeting CD7-positive Malignancies",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 1",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "T-cell Acute Lymphoblastic Leukemia",
                "T-cell Acute Lymphoblastic Lymphoma",
                "Acute Myeloid Leukemia",
                "NK Cell Lymphoma"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 30,
            "start_date": "2027-06-30",
            "registry_url": "https://clinicaltrials.gov/study/NCT05995028"
        },
        {
            "nct_id": "NCT07501156",
            "title": "H3K27M-specific Immune Effector Cells Targeting DMG/DIPG",
            "status": "NOT_YET_RECRUITING",
            "phase": "Phase 1/2",
            "lead_sponsor": "Shenzhen Geno-Immune Medical Institute",
            "conditions": [
                "Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma"
            ],
            "sites": [
                "Shenzhen"
            ],
            "enrollment": 30,
            "start_date": "2027-06-30",
            "registry_url": "https://clinicaltrials.gov/study/NCT07501156"
        }
    ]
}